SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Misonix Inc. (MSON)
MSON 26.540.0%Nov 22 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Candle stick who wrote (815)9/22/1998 5:28:00 PM
From: Beltropolis Boy  Read Replies (1) of 947
 
thread: while i'm generally loathe to make predictions, particularly when it comes to stocks (much less the steelers), i think FY99 will be misonix's year. every time i take a look at this company's fundamentals, i am often baffled (admittedly, it generally doesn't take much) by its meager valuation. i know, i know, about the patent infringement issue, but bear with me.

first off, as we all know, we've got a solid product base in a niche market with a good license agreement. healthy profit margin of 20%, ROE of 32%, negligible debt, and EPS growing nicely. regarding the latter, if the trend continues, FY99 will represent the first year where fair comparisons can be made to the prior year (if you'll recall, we had that nasty non-recurring, non-compensation options charge in 3QFY97), and the second full year of ultrasonic surgical device sales.

looking at diluted earnings, i've got $0.76 EPS for FY98 ($0.09, $0.14, $0.16, and most recently, $0.37). while i don't have estimates for next year, i think it's fair to say the sequential trend can continue. get this lawsuit mess out of the way, and this is crucial, a half decent multiple, and we'll pop into the double digits.

your thoughts are welcome,
-chris.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext